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Abstract: - Disease psoriasis occurs as chronic inflammation of skin and appears as scaly red lesions on skin 
surface. Advent of several immunosuppressive drugs established that the disease stems from immuno-
pathogenic disorder in human blood. Cell biological as well as clinical research on the disease reveals that the 
helper T-cells and other Leucocytes, responsible for human immunity, may lead to psoriasis pathogenesis if 
produced in plenty at locations close to the dermal region. Research findings also showed that a complex, self-
sustaining (cytokine and related) proteins network play important role in disease maturation by actually leading 
to a huge proliferation of epidermal keratinocytes. Disease pathogenesis is identified with such 
hyperproliferation leading to flaking of skin surface (psoriatic plaques). An excessive generation of nitric oxide 
by proliferated keratinocytes, through a complex chain of bio-chemical events, is causal to the scaliness of 
psoriatic plaques. Considering these immunopathogenic mechanisms, we propose and analyse a mathematical 
time differential model for the disease psoriasis. Outcomes of analysis are consistent with existing cell 
biological and clinical findings with some new predictions which could be tested further. 
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1 Introduction 
The terminology psoriasis is inherently linked to the 
connotation ‘soreness of skin’ which essentially 
implies a disease occurring as chronic inflammation 
of skin. Actually, the disease psoriasis is manifested 
as scaly red lesions on the skin surface termed as 
plaques. Presently, more than 3 % of the world 
population is affected by the disease and there is 
significant morbidity. As of now, exact mechanism 
leading to the disease is not precisely understood. 
Consequently, any specific and systematic therapy 
to completely cure the disease has not yet been 
evolved. Under the present circumstances, it is 
generally believed that the exact causes for 
infliction of the disease psoriasis are yet to be fully 
understood and hence psoriasis is incurable. 
However, clinical and cell biological research, till 
date, point towards various genetic, environmental 
and immunological factors contributing to 
pathogenesis of the disease [1-4].  
It is being evidenced by clinical research that 
psoriasis is caused due to a breakdown in the human 
(mammalian) immune system where the disease 
fighting immune cells (T-cells) virtually attack the 
healthy skin cells due to some erroneous signaling 
[5].  This conclusive statement is emboldened by the 
fact that, immunosuppressive drugs like 
cyclosporine A, which inhibits T-cell proliferation 
and cytokine production, have been observed 
effective in treating psoriatic lesions [6]. Further, 
trials with anti-CD4 monoclonal antibodies and IL-2 
toxin conjugate on psoriatic patients have found 
remedial response to psoriatic plaques [7, 8]. Thus, 
psoriasis is being characterized as an autoimmune 
disease and is probably the most prevalent in the 
category [9-11].   
Disease maturation in psoriasis is observed to be 
led by hyperproliferation of epidermal keratinocytes 
which produces thickening or flaking of epidermis 
[12]. Within the psoriatic skin lesions, a sizeable 
influx of myeloid dendritic cells takes place [13] 
leading to substantial generation of cytokine 
TNF−𝛼 and thus causing inflammation of epidermis 
[14]. In addition, high levels of cytokines (proteins) 
such as IFN−𝛾, IL-17, TGF−𝛽 have been found in 
psoriatic skin as in other inflammatory diseases [15-
18]. Further, epidermal keratinocytes in psoriatic 
plaques produce the enzyme i-NOS (inducible nitric 
oxide synthase) which gives way to massive nitric 
oxide production [19, 20]. In fact, nitric oxide 
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production in psoriatic epidermis seems to be ten 
times higher than that in non-psoriatic epidermis 
with normal level of keratinocytes [21]. This 
massive nitric oxide, produced through i-NOS 
pathway at the cost of hyperproliferated 
keratinocytes, induce over-sensitivity in the 
psoriatic plaques and hence their redness [22]. 
A complex cytokine network is closely linked to 
the process of pathogenesis in case of psoriasis. 
Actually, various cytokines, chemokines, growth 
factors, which are broadly clubbed in the protein 
category, are vital for the disease maturation [14-18, 
23, 24]. Cytokines IFN−𝛾, TNF-𝛼  IL-2, which are 
secreted by T-helper 1 (Th-1) cells, are predominant 
in psoriasis, out of which IFN- is produced by 
CD4+T and CD8+T cells. It has been observed that 
lesions can be induced by intradermal injection of 
IFN−𝛾[15]. Cell biological research testifies that 
Leucocytes (immune cells) and keratinocytes can 
produce various cytokines and chemokines [12]. In 
fact, Th-1 cytokines IFN−𝛾 and TNF−𝛼induce 
keratinocytes to further produce other cytokines like 
IL-6, IL-8, IL-12, and IL-18 [25-28]. A type of 
leukocyte, termed as dendritic cells, secretes the 
cytokine IL-23 which, in turn, stimulates T-helper 
17 leucocytes to add to the production of other 
cytokines such as IL-17A, IL-17F, IL-6, IL-22 and 
TNF-𝛼 [17]. Various proteins, such as cytokines, 
chemokines, growth factors, get synergized 
mutually within themselves to further enhance their 
weight (density) in the blood and thereby increase 
influx of leucocytes in the epidermal skin as well as 
cause keratinocyte hyperproliferation [12]. Proteins 
also increase apoptotic resistance of keratinocytes. 
Increased influx of leucocytes in the skin gets 
induced by keratinocytes and contributes to further 
proliferation of epidermal keratinocytes [29]. The 
protein network (comprising of cytokines, 
chemokines, growth factors etc) in psoriasis is, thus, 
a self sustaining phenomenon which immensely 
influence and regulate pathogenesis in psoriasis. As 
perceived by clinical and cell-biological research, 
interplay between these proteins in a fairly complex 
network can explain most of clinical features in 
psoriasis. 
Information gathered from clinical and cell-
biological investigations, as portrayed above, when 
sequenced systematically, point towards a logical 
and formative depiction, of which a mathematical 
archetype can be framed. Framing of such archetype 
is termed as the process of mathematical modeling 
in general and for the present case it is for the 
disease psoriasis. In this communication, we wish to 
formulate, in detail, a density type mathematical 
model to represent immunopathogenesis for the 
disease psoriasis. We would also like to perform an 
in-depth analysis of the mathematical model, so 
formulated, to bring forth relevant and salient results 
and some predictions suggestive of cure from the 
disease, which could be tested further clinically. 
The paper is organized as follows. In section-2 
we describe, in detail, the process of framing the 
mathematical archetype for the disease psoriasis. 
With a suitable background-narration and having 
detailed the assumptions leading to the density type 
mathematical archetype of the disease psoriasis, 
theoretical analysis relating the stabilities of the 
model is being taken up in Section-3. In section-4, 
we take up the task for analyzing detailed of the 
model through the numerical avenue. Results from 
the numerical analysis have also been discussed in 
Section-4. Some concluding remarks including new 
predictions as well as future directions of work in 
the area, is being presented in Section-5. 
 
2 Formulation of the mathematical 
archetype 
 Accumulating research results from the clinical and 
cell biological investigations, emergence of a 
mathematical model to represent immuno-
pathogenesis in psoriasis can be asserted, albeit with 
logical and coherent sequencing of such results. The 
mathematical model in question is a set of time 
differentials of some associated variables 
representing population/mass densities of biological 
cell/molecules, with these differentials equated to 
significant cell-biological processes of associative 
relevance, involving a set of model parameters. 
     Based on clinical and cell-biological findings, a 
preliminary model was earlier proposed involving 
densities of T-cells, dendritic cells and keratinocytes 
as model variables [30-32]. This preliminary model, 
on being analyzed, signified disease pathogenesis in 
some region of parameter space, but the results were 
menacingly simple and abnormally linear in nature. 
A fundamental reason for such shortcomings has 
been the overlooking of important role of cytokines, 
chemokines, growth factors and such other proteins 
in the process of psoriasis pathogenesis. This 
realization of the significance of proteins in 
psoriasis, as depicted in the introduction part in this 
article, makes us to assert that proteins need direct 
inclusion in the mathematical archetype of psoriasis. 
       Taking leads from the clinical and cell 
biological rulings, as in the introduction, here we 
give a linguistic depiction of the mathematical 
model for psoriasis, narrating the processes that 
either enrich or degrade a model variable. Let us 
consider that, 𝑙𝑒𝑢𝑐𝑜𝑐𝑦𝑡𝑒𝑠 (𝐿), 𝑝𝑟𝑜𝑡𝑒𝑖𝑛𝑠 (𝑃) and 
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𝑘𝑒𝑟𝑎𝑡𝑖𝑛𝑜𝑐𝑦𝑡𝑒𝑠 (𝐾) represent three model variables. 
Cell-biological processes linked to time differential 
of Leucocytes are:  
 
(a) An upstream influx of T-cells dendritic cells and 
other leucocytes in the affected region of 
epidermis. 
(b) Various proteins contribute to leucocyte 
population, 
(c) Loss of leucocytes through their contribution to 
proteins and through other natural processes.  
 
Processes related to time variation of proteins are:  
 
(a) Secretion of various proteins by leucocytes.  
(b) Keratinocytes in conjugation with proteins 
contribute further to protein density.  
(c) Loss of proteins through their giving in to 
leucocytes and to hyperproliferation of 
keratinocytes.  
 
Time variation of keratinocytes is being associated 
to the following processes:  
 
(a) Leucocyte stimulate keratinocytes to proliferate, 
(b) Proteins directly yield to keratinocyte 
hyperproliferation.  
(c) Loss of keratinocytes through its contribution to 
proteins. 
(d) Loss of proliferated keratinocytes owing to nitric 
oxide production through i-NOS pathway.  
 
    Having stated the dominant cell-biological and 
allied phenomena linked to the three model 
variables 𝐿,𝑃 and 𝐾   in units of 𝑚𝑚−3 , we 
proceed for narrating the customary assumptions to 
arrive at the basic model in mathematical 
connotation. Following are the assumption:  
 
 A1. We assume an influx of leucocytes (immune 
cells) at a constant rate ‘a’ in the proximal spatial 
region of the dermal skin prospective to be affected 
by psoriasis. Predominantly the leucocytes, of T-
cells and dendritic cells category, are prone for 
upstream influx. 
 
A2. To cohere to the essence of A1, it is assumed 
that the relevant leucocytes are not reproduced on 
their own, by any mechanism or in any form. 
 
A3. We assume that leucocytes, being stimulated, 
contribute to the production of proteins at a constant 
rate  𝜷 (∈ 𝑅+). Various proteins such as cytokines, 
chemokines, growth factors etc., in turn, directly 
yield to the proliferation of leucocytes at the 
relevant region of space at a constant rate 𝜶 (∈ 𝑅+). 
Such proliferation of leucocytes is entirely due to 
the protein mass by stimulation. 
 
A4. It is assumed that leucocytes, being induced by 
keratinocyte mass, further add to the growth of 
epidermal keratinocytes at the rate 𝜂 (∈ 𝑅+). 
 
A5. We assume that various proteins directly yield 
to the hyperproliferation of keratinocyte mass at a 
rate 𝜂′(∈ 𝑅+).  
 
A6. Proliferated keratinocytes are assumed to have 
propotional interaction with the protein mass and 
such interactions lead to the enhancement of protein 
mass at a rate  𝛿 (∈ 𝑅+). 
 
A7. A per capita removal of leucocytes at the rate 
𝜇 (∈ 𝑅+) is assumed, which is attributed to the loss 
of leucocytes owing to natural processes and for 
their (leucocytes) contributing to the protein 
concentration as well as keratinocyte proliferation. 
 
A8. A per capita removal of proteins at the rate 
𝜆 (∈ 𝑅+) is assumed on account of their 
contributing to leucocyte and keratinocyte 
concentrations.  
 
A9. We assume removal of keratinocytes at a rate 
𝛾 (∈ 𝑅+), owing to their interaction with proteins 
and their eventual contribution to the protein mass.  
 
A10. We assume a per capita loss of keratinocyte 
mass, at a constant rate 𝝀′(∈ 𝑅+), due to its 
generating nitric oxide through i-NOS pathway [33, 
34]. 
 
The above assumptions A1-A10, while 
considered together, lead to three time differential 
equations for the variables 𝐿,𝑃 and 𝐾 as  
                      
𝑑𝐿
𝑑𝑡
= 𝑎 + 𝛼𝑃 − 𝜇𝐿  
 
𝑑𝑃
𝑑𝑡
= 𝛽𝐿 + 𝛿𝑃𝐾 − 𝑃                                      (1) 
 
𝑑𝐾
𝑑𝑡
= 𝐿𝐾 + ′𝑃 − 𝛾𝑃𝐾 − ′𝐾 
 
This set of three time differential equations (1), 
actually contribute to the mathematical archetype or 
model of the disease psoriasis and these model 
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equations can be analyzed to understand the 
immunopathogenesis in psoriasis.  
 
3 Analyses on Model Stability  
By observation, it can be asserted that right hand 
side of the model equation (1) are smooth functions 
of variables 𝐿, 𝑃, 𝐾 and the various model 
parameters defined in the earlier section. While 
forming the model equation we have inherently 
assumed that the model variables 𝐿, 𝑃, 𝐾 and the 
model parameters are all non-negative and these 
assume values on the real lines. Thus it can be 
emphasized that the solutions of the model 
equations do have local existence in specified 
domains as well as they hold uniqueness and 
continuity properties in the positive octant of co-
ordinate space. 
     The model equations (1) may further be analyzed 
to judge the existence of different equilibria  which 
would signify the stability of the allied biological 
system. In general, the following equilibrium may 
exist on the different co-ordinates planes. These 
equilibria are: (i) 𝐸1(𝐿1
∗ ,0,0) with 𝐿1
∗ =  𝑎/µ and the 
parameter 𝑎 = 0 is a possibility. (ii) 𝐸2(𝐿2
∗ ,𝑃2
∗, 0) 
with   𝐿2
∗ =
𝑎𝜆
𝜇𝜆−𝛼𝛽
    &   𝑃2
∗  =
𝑎𝛽
𝜇𝜆−𝛼𝛽
      and         
(iii) 𝐸∗(𝐿∗,𝑃∗,𝐾∗) where the asymptotic stable 
values of variables can be obtained by solving the 
following equations 
𝑎 + 𝛼𝑃∗ − µ 𝐿∗ = 0 
𝛽𝐿∗ + 𝛿𝑃∗𝐾∗ − 𝜆𝑃∗ = 0                                           (2)  
𝜂𝐿∗𝐾∗ + 𝜂′𝑃∗ − 𝛾𝑃∗𝐾∗ − 𝜆′𝐾∗ = 0      
     
Equations (2) can be solved for asymptotic stable 
values of model variable which turns out to be  
𝑃∗ =
µ𝐿∗ − 𝑎
𝛼
                             (3.𝑎) 
𝐾∗ =
𝜂′(µ𝐿∗ − 𝑎)
𝛼𝜆′ + 𝛾 µ𝐿∗ − 𝑎 − 𝛼𝜂𝐿∗
                 (3. 𝑏) 
And 𝐿 ∗ could be obtained from 
𝐿∗2 𝑥𝑦 + µ2𝑣 + 𝐿∗ 𝑥𝑧 + 𝝀𝑎𝑦 − 2µ𝑎𝑣 +
                                               𝜆𝑎𝑧 + 𝑎2𝑣 = 0          (4)  
With  
𝑥 = (𝛼𝛽 − 𝜆𝜇), 𝑦 = (𝛾𝜇 − 𝛼𝜂), 𝑧 = (𝛼𝜆′ − 𝛾𝑎),  
𝑣 =  𝛿𝜂′ 
Equation (4) yields solutions for 𝐿∗ as    
𝐿∗ =
− 𝑥𝑧+𝝀𝑎𝑦−2µ𝑎𝑣 ±   𝑥𝑧+𝝀𝑎𝑦−2µ𝑎𝑣 2−4 𝑥𝑦+µ2𝑣  𝜆𝑎𝑧+𝑎2𝑣  
2 𝑥𝑦+µ2𝑣 
  
 𝐿∗  would assume values on real line provided  
 
 𝑥𝑧 + 𝝀𝑎𝑦 − 2µ𝑎𝑣 2 − 4 𝑥𝑦 + µ2𝑣  𝜆𝑎𝑧 + 𝑎2𝑣   
                                                                                    ≥ 0. 
Further analyzing the above conditional relation we 
obtained the following condition on the numerical 
values of parameter 
 
   𝛼𝛽 >  ,   𝜆𝜂 > 𝛽𝛾                           (5.𝑎)   
and  
𝛼𝜆′ > 𝛾𝑎,    𝑎𝜂 > 𝜇𝜆′                            5. 𝑏       
 
 Note that the last equilibrium 𝐸∗(𝐿∗,𝑃∗,𝐾∗) 
signifies the general stability of the asymptotic 
solutions and the allied parametric relations are 
useful in standardizing the model parameters. This 
𝐸∗ is also termed as the interior equilibrium of the 
mathematical model and its existence is dependent 
on the imposing conditions, as equations (5) so 
derived, relating various model parameter. 
     Let us judge the stability of the general 
equilibrium 𝐸∗(𝐿∗.𝑃∗, 𝐾∗) of the model under 
consideration which necessitates finding out the 
Jacobian matrix for the model [35]. For this purpose 
one needs to linearize model equations (1) around 
the equilibrium point by introducing a set of new 
variables which measure the deviation about the 
equilibrium. Thus we introduce      
  𝑋 𝑡 = 𝐿 𝑡 − 𝐿∗                                                                                                      
  𝑌 𝑡 = 𝑃 𝑡 − 𝑃∗                       (6)                                                                                                
  𝑍 𝑡 = 𝐾 𝑡 − 𝐾∗ 
We then linearize the model equations (1) about the 
general equilibrium 𝐸∗ following standard 
procedure and we get the matrix equation  
  
𝑋 
𝑌 
𝑍 
=  
−𝜇 𝛼 0
𝛽 𝛿𝐾∗ − 𝜆 𝛿
𝜂𝐾∗ 𝜂′ − 𝛾𝐾∗ 𝜂𝐿∗ − 𝛾𝑃∗ − 𝜆′
   
𝑋
𝑌
𝑍
  
         = 𝐉  
𝑋
𝑌
𝑍
                                                         (7) 
Where J is called the Jacobian Matrix.  
Since we are interested about the stability of the 
general equilibrium 𝐸∗(𝐿∗, 𝑃∗,𝐾∗) we apply the 
Routh-Hurwitz criterion [35] for the Jacobian in the 
above matrix equation to obtain the conditions  
         𝑇𝑟 𝑱 < 0 and 𝑑𝑒𝑡 𝑱 > 0.                (8) 
Our calculations yield the values of trace and 
determinant of the Jacobian as,  
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𝑇𝑟 𝑱 = − 𝜇 + 𝜆 + 𝜆′ + 𝛿𝐾∗ + 𝜂𝐿∗ − 𝛾𝑃∗         (9) 
and,  
det J= 𝜂𝜆 𝜇 − 𝛽 𝐿∗ +  𝜂′𝜇𝛿 − 𝜇𝜆𝛾 + 𝛾𝛼𝛽 𝑃∗ +
    𝜆′𝜇𝛿𝐾∗ − 𝜇𝛿𝜂𝐿∗𝐾∗ + 𝛼𝜂𝛿𝑃∗𝐾∗ + 𝜆′(𝜇𝜆 + 𝛼𝛽)    (10) 
      
 Further, we find that in our model as defined in 
equations (1), Routh-Hurwitz criterion is satisfied 
for the interior equilibrium 𝐸∗ and hence we may 
assert that the system is locally asymptotically 
stable around the general equilibrium 𝐸∗(𝐿∗, 𝑃∗, 𝐾∗). 
 
4 Analyses In The Numerical Avenue 
Numerical solution of the model equation (1) 
becomes a necessity in order for graphical 
illustration and visualization of the dynamical 
progression of the model outcomes. Detailed 
understanding of the model dynamics can be 
achieved through numerics of the model equations. 
Further, numerical solutions make it possible to 
study the effect of model parameters on model 
dynamics and lead to estimation of various 
thresholds existing within the model. 
 
Table 1: Default values of Model Parameters 
 
Parameter Definition Default Values 
𝑎 
Rate of influx of 
Leucocytes 5  mm
-3 
Day 
-1
 
𝛼 
Rate of growth of 
Leucocytes out of 
Proteins  
0.03 
 
Day 
-1
 
𝜇 
Per capita removal 
of Leucocytes 0.18  Day 
-1
 
𝛽 
Growth rate of 
Proteins out of 
Leucocytes 
0.0005 Day 
-1
 
 
Growth rate of 
Proteins by P & K 
mixing 
0.0001 mm
3
 Day 
-1
 
 
Per capita removal 
of Proteins 0.08 Day 
-1
 
 
Growth rate of 
Keratinocytes by L 
& K 
0.011 mm
3
 Day 
-1
 
′ 
Growth-rate of 
Keratinocytes due 
to P 
0.0005 Day 
-1
 
𝛾 
Rate of reduction of 
Keratinocytes by  
its interaction with 
Proteins 
0.0001 mm
3
 Day 
-1
 
′  
Rate of removal of 
Keratinocytes for i-
NOS & for giving 
in to Proteins 
0.06 Day 
-1
 
 In order to solve the model equations 
numerically one needs to assign default or standard 
numerical values to the set of model parameters and 
the same is done in Table 1. In the present case, 
standardization of parameters are done, 
predominantly by going through the accumulated 
clinical data on psoriasis and based on the so far 
achieved experimental results in the domain of cell-
biological research on psoriasis. It is to be noted 
here that the potential tool of numerical solution has 
also been used extensively as one in many 
acceptable processes of standardization of model 
parameters. Actually, taking maiden leads from 
clinical and cell-biological research findings, some 
judicious or suitable values of model parameters are 
chosen and then all the model parameters are varied 
in wide ranges to get solutions of model variables 
from equations (1). Thus, continually judging the 
numerical solutions of model equations, the 
standard value of each parameter has been reached 
by repeated numerical trials. Imposing condition 
involving model parameters, as yielded by 
theoretical analysis on model (solution) stability 
have also been borne in mind during the process of 
standardization of default parameter values. 
 Considering default model parameters values as 
demonstrated in Table 1, model equations (1) are 
solved numerically. Results from such numerical 
solutions are explained through relevant planar 
viewgraphs termed as figures. Primarily, the time 
series solutions of model variables are analyzed to 
understand their dependences on various model 
parameters and then, asymptotic solutions of model 
variables are studied for changing values of 
parameters to bring out characteristic dependences 
of asymptotic solutions on various model 
parameters.  
 
Fig.1: Time series solutions of model variables 
for two different values of a, as depicted.  
 
       In Fig.1, we plot time series solutions for 
variables 𝐿, 𝑃 and 𝐾 as functions of time (taken in 
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days) for two different values of parameter 𝑎 
denoting the rate of upstream influx of leucocytes. 
An increase in 𝑎 signifies considerable dying down 
of oscillations in 𝐿(𝑡), 𝑃(𝑡) and 𝐾(𝑡) as well as an 
enhancement of asymptotic values of solutions 
including that of asymptotic Keratinocyte density 
𝐾(𝑡). Thus an increased 𝑎 seems to favour psoriasis 
pathogenesis and the reverse process, that is 
considerable lowering in 𝑎,  implies a roll back from 
pathogenesis.  
 
 
 
Fig.2: Time series solutions of model variables 
for two different values of 𝛼, as given in the 
figure.   
 
 
Fig.3: Time series solutions of model variables 
for two different values of model parameter 𝛽.  
 
Solutions for leucocytes (𝐿), proteins (𝑃) and 
keratinocytes (𝐾) are plotted as a function of time 
(in days) for two different chosen values of the 
parameters 𝛼 , the growth rate of leucocytes owing 
to proteins, in Fig.2. We find here that for smaller 𝛼,  
solutions remain oscillatory till a very large time, 
whereas, with higher 𝛼 the solutions become single 
valued and stable much faster. It is apparent from 
the viewgraph that with 𝛼 = 0.005 𝑃(𝑡) and 𝐾(𝑡) 
remains oscillatory and multi-valued even at a fairly 
large time 𝑡 = 1500 days. But with an increase of 𝛼 
by an order of magnitude at 0.03, all three variables 
equilibrate to single valued solutions at around 
𝑡~900 days. Increase in 𝛼 is accompanied by 
nominal increase in the asymptotic leucocytes’ 
density. 
 Plot of 𝐿(𝑡), 𝑃(𝑡) and 𝐾(𝑡) solutions, for 
different 𝛽 denoting the rate of protein growth 
owing to lucocytes, has been included in Fig.3. 
Parameters other than 𝛽 are kept at their 
standardized values as in Table 1. 
 Increase in 𝛽 plays such that the single valued-
ness of solutions are reached considerably faster on 
time scale. Significant fall in the asymptotic stable 
value of keratinocyte density (𝐾), for increasing 𝛽, 
is note-worthy. Asymptotic values of leucocyte 
(𝐿) and protein (𝑃) masses remain almost 
insensitive to change in 𝛽, as observed in the 
plot. 
 
 
Fig.4: Solutions for model variables as function 
of time for two different values of model 
parameter 𝛿.  
 
 Fig.4 contains plots of time series solutions of 𝐿, 
𝑃 and 𝐾 masses for two different values of the 
parameter 𝛿, representing growth rate of proteins 
owing to its mixing with keratinocyte mass. Here 
we find that all three solutions become single valued 
at a fairly smaller time 𝑡~500 days when compared 
to the solutions in the earlier figures. We also 
observe that increase in 𝛿 makes the asymptotic 
keratinocyte density to degrade drastically and 𝑃(𝑡) 
oscillation amplitude is higher at small  𝑡. 
    In all the above figures, we presented time series 
solutions of model variables as functions of time 
taken in units of days. A keen observation reveals 
that asymptotically all the solutions become single 
valued and stable irrespective of the numerical 
values assigned to the parameters. It is also apparent 
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that there are situations where asymptotic 
keratinocyte density stabilizes at high values 
signifying psoriasis pathogenesis. However, in such 
pathogenic solutions conditions, we always find that 
solutions equilibrate to single valued stable state at a 
large time 𝑡~1500− 1700 days. This phenomenon 
manifestly shows that disease maturation (or the 
process of pathogenesis) in psoriasis requires a long 
time which is compatible to those observed by the 
researches in the clinical domain. 
 
Fig.5: Phase-diagram depicting dependences of 
asymptotic stable solutions of model variables 
(𝐿∗,𝑃∗,𝐾∗) with varying model parameter a.  
 
 Next we would like to present numerical results 
pertaining to the phase diagram of model variable 
(solutions) as function of different model 
parameters. Here we actually produce plots of 
asymptotic (stable) solutions for model variables 
with varying model parameters. It should be noted 
that for solving differential model equations we 
have set the time-step at ∆𝑡 =  0.001 and explored 
up to 𝑡 = 2000 days so that the solutions are really 
asymptotic for all practical purposes. 
 Fig.5 represents phase diagram involving 
asymptotic stable densities of model variables 
𝐿∗, 𝑃∗ and 𝐾∗ plotted as a function of the parameter  
𝑎  while all other parameters are kept at their default 
values as in Table 1. We observe that fixed values 
of variables 𝐿∗ = 𝐿(𝑡 → ∞), 𝑃∗ = 𝑃(𝑡 → ∞) and 
𝐾∗ = 𝐾(𝑡 → ∞) are all negligibly small for very 
small values of 𝑎. With increasing 𝑎,  𝐿∗ and P* 
increase steadily and in a near-linear fashion, 
whereas 𝐾∗ suffers an abrupt high-hill jump at 𝑎~1. 
Just beyond 𝑎~1, the asymptotic keratinocyte 
density assumes the numerical value 𝐾∗ ≈ 800, 
which may be termed as the globally stable value of 
the keratinocyte density for the chosen set of model 
parameters. Results in the viewgraph indicates a 
threshold for leucocytes influx rate 𝑎𝑡ℎ~1.0 beyond 
which disease pathogenesis in psoriasis sets in as 
manifested by the abrupt jump in 𝐾∗.  
Fig.6: Asymptotic stable solutions of model 
variables (𝐿∗,𝑃∗,𝐾∗) with changing model 
parameter 𝛼.  
 
 Phase diagram for varying model parameter 𝛼, 
the growth-rate of leucocytes owing to proteins, has 
been included in Fig.6. Except varying the 
parameter 𝛼, we keep all other parameters at their 
default values as in Table 1. We find that 𝐿∗ and 𝑃∗ 
increase slowly and monotonically at very small 𝛼 
and beyond some value of 𝛼~0.12, asymptotic 
stable solutions of leucocytes (𝐾∗) and proteins (𝑃∗) 
register almost exponential rise and diverges beyond   
𝛼~0.17 . Notice that for very small 𝛼, 𝑃∗ solutions 
are multi-valued. Asymptotic solutions for 
keratinocytes’ density 𝐾∗ is also multi valued at 
small 𝛼 < 0.01 bounded in a range 400-1200 (in 
mm
-3
). However single valued saturation at 𝐾∗~800 
signifying a sharp disease pathogenesis beyond 
𝛼𝑡ℎ~0.01.  
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Fig.7: phase diagram involving asymptotic stable 
solutions of model variables (𝐿∗,𝑃∗,𝐾∗) with 
changing model parameter 𝛽.  
  
In Fig.7 we incorporate plots of 𝐿∗, 𝑃∗ and 𝐾∗ as 
functions of varying model parameter 𝛽, that gives 
the rate of growth of proteins due to leucocytes. At 
very small 𝛽, 𝐿∗ and 𝑃∗ are flat, but beyond 
𝛽~0.08, both leucocytes (𝐿∗) and proteins (𝑃∗) 
densities rise steeply. With increasing 𝛽, 
keratinocyte stable density 𝐾∗ drops linearly from 
its saturation value ~800 at a fast pace and becomes 
negligibly small beyond a threshold of 𝛽𝑡ℎ~0.065. 
This viewgraph clearly indicates that at a moderate 
or large value of 𝛽 beyond the 𝛽𝑡ℎ , keratinocytes’ 
density assumes very small numerical value with 
leucocytes (𝐿∗) and proteins (𝑃∗) densities being 
substantial. This Phenomenon points towards a 
sustainable roll-back from disease pathogenesis.  
 Fig.8 represents phase diagram of asymptotic 
model variable solutions with changing 𝛿 (protein 
growth rate owing to its mixing with keratinocytes). 
At very small 𝛿 (near zero), 𝐿∗ and 𝑃∗ are at their 
moderately small values whereas keratinocytes 
density is at its saturation 𝐾∗~800. With increasing 
𝛿, 𝐿∗ registers very little or almost no rise in its 
values while 𝑃∗ rises at low pace.  However, 
increase in 𝛿 makes asymptotic keratinocytes’ 
density 𝐾∗ to have a sharp fall. Thus we may assert 
that with increasing values of model parameter 𝛿 
signature of pathogenesis in the disease psoriasis get 
smeared out. 
 
Fig.8: Asymptotic stable solutions of model 
variables 𝐿∗,𝑃∗ and  𝐾∗ with changing model 
parameter 𝛿.  
Fig.9: phase diagram involving asymptotic stable 
solutions of model variables (𝐿∗,𝑃∗,𝐾∗) with 
changing model parameter 𝛽.  
 
Phase diagram of varying parameter 𝜂 is 
presented in Fig.9 where 𝜂 stands for growth rate of 
keratinocytes owing to its mixing with leucocytes. 
At very small 𝜂 (< 0.015), 𝐿∗ is small and 𝑃∗ & 𝐾∗ 
are negligibly small. With increasing  𝜂, asymptotic 
leucocyte density 𝐿∗ registers like-exponential rise 
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and nearly diverges beyond 𝜂~0.055 and 
asymptotic protein density 𝑃∗ rises faster than 𝐿∗ 
and also diverges beyond 𝜂~0.05. Asymptotic 
keratinocytes’ density 𝐾∗, from a very small value 
at small 𝜂, jumps to its globally stable saturation 
value ~800 at a threshold 𝜂𝑡ℎ~0.0015. It can be 
asserted accordingly that disease pathogenesis 
occurs abruptly at a threshold 𝜂𝑡ℎ~0.0015. 
 
5 Conclusions and Further Work  
The disease psoriasis, though manifested as 
chronic inflammation of skin, has its root to 
imbalances inflicted in the immune system of 
human (or any other mammalian) blood. As 
established by so far accumulated literature the 
disease is also termed as an autoimmune disease. 
 We, in this communication, developed a 
mathematical model for the autoimmune disease 
psoriasis based on the clinical and cell-biological 
evidences. The mathematical archetype has been 
framed on the buildup of a set of assumptions which 
are substantiated rightfully by clinical and cell-
biological rulings gathered till date in the allied 
literature. 
The mathematical model consists of three time 
differential equations involving pertinent 
cellular/biochemical masses that serve as model 
variables and these are connected to sequences of 
biological processes (or phenomena) being depicted 
in terms of a set of parameters symbolizing the 
strength of these biological processes or 
phenomena. The model, as a whole, actually 
provides population dynamic behaviors of variable 
masses of leucocytes, various proteins (cytokines, 
chemokines, growth factors) and the epidermal 
keratinocytes, where abnormally high proliferation 
of epidermal keratinocytes is implicative of disease 
pathogenesis. In our theoretical and numerical 
studies on the model, we have extensively explored 
effects of various model parameters on the 
dynamical progression of model variable masses 
and found that disease pathogenesis in psoriasis 
does exist within the model. Consequently, we also 
observe that interplay of some model parameters at 
specified strengths could signify sharp backtracking 
from disease pathogenesis. 
With our analysis on the model we could 
establish that asymptotic solutions of the model are 
stable in the wide ranges of various model 
parameters. With the tool of numerical analysis 
being applied extensively in case of the present 
model, we could estimate (with considerable 
accuracy) numerical thresholds of some model 
parameters that inflict onset of or roll back from 
disease pathogenesis within the model. Note that, 
although we have embarked on the tempting 
practice of generating a set of default-valued model 
parameters. In actual practice, all the model 
parameters are varied in their respective permissible 
ranges capped by theoretical analysis. 
We find that the model shows termination of 
disease pathogenesis when influx of leucocytes 
(signified by the strength of parameter 𝑎) is 
decreased below a threshold. Such roll-back from 
pathogenesis is analogous to T-cell (leucocytes) 
suppression by immuno-suppressive drugs 
improvised in clinical therapies. We further observe 
that an enhanced secretion of proteins by leucocytes, 
which is achieved within the model by increasing 
the parameter  𝛽, leads to a sustainable  termination 
of disease pathogenesis and an increase in parameter 
𝛿, representing the growth factor of proteins owing 
to its mixing with keratinocytes, also inflicts a 
smearing out of signatures of pathogenesis. These 
results are two important predictions from analysis 
of the present model which could be put to future 
clinical test. 
Further work in the allied area would include a 
detailed justification of the default set of model 
parameters, exploration of added substantiating 
evidences (clinical and cell-biological) for the set of 
assumptions leading to the mathematical archetype 
and inclusion of realistic (parametric) functional 
dependence of biological processes involved within 
the model. We are also inclined to explore the 
possibility of applying our understanding of the 
present model in case of any other ailments 
pertaining to immune system.  
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